PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024
PHAXIAM Therapeutics has released its monthly report on voting rights and share capital composition for November 29, 2024. The company's total shares remained stable at 10,013,719 since October 2024. The gross voting rights slightly increased to 10,166,025, while net voting rights stood at 10,165,776.
Notable changes occurred in July 2024 when the total shares increased from 6,075,105 to 9,980,668, representing a significant expansion in the company's share capital. The report includes monthly data from December 2023 through November 2024, tracking both gross and net voting rights in accordance with French Autorité des Marchés Financiers regulations.
PHAXIAM Therapeutics ha pubblicato il suo rapporto mensile sui diritti di voto e sulla composizione del capitale azionario per il 29 novembre 2024. Il numero totale di azioni della società è rimasto stabile a 10.013.719 dal ottobre 2024. I diritti di voto lordi sono leggermente aumentati a 10.166.025, mentre i diritti di voto netti si sono attestati a 10.165.776.
Modifiche significative si sono verificate a luglio 2024, quando il numero totale di azioni è aumentato da 6.075.105 a 9.980.668, rappresentando un'espansione significativa del capitale azionario della società. Il rapporto include dati mensili da dicembre 2023 a novembre 2024, monitorando sia i diritti di voto lordi che quelli netti in conformità con le normative dell'Autorité des Marchés Financiers francese.
PHAXIAM Therapeutics ha publicado su informe mensual sobre los derechos de voto y la composición del capital social para el 29 de noviembre de 2024. El total de acciones de la empresa se mantuvo estable en 10.013.719 desde octubre de 2024. Los derechos de voto brutos aumentaron ligeramente a 10.166.025, mientras que los derechos de voto netos se situaron en 10.165.776.
Cambios notables ocurrieron en julio de 2024 cuando el total de acciones aumentó de 6.075.105 a 9.980.668, lo que representa una expansión significativa en el capital social de la empresa. El informe incluye datos mensuales desde diciembre de 2023 hasta noviembre de 2024, rastreando tanto los derechos de voto brutos como netos de acuerdo con las regulaciones de la Autorité des Marchés Financiers francesa.
PHAXIAM Therapeutics는 2024년 11월 29일에 투표권과 자본 구성에 대한 월간 보고서를 발표했습니다. 회사의 총 주식 수는 2024년 10월 이후 10,013,719로 안정적으로 유지되었습니다. 총 투표권은 소폭 증가하여 10,166,025에 달했고, 순 투표권은 10,165,776으로 집계되었습니다.
2024년 7월에는 총 주식 수가 6,075,105에서 9,980,668로 증가하여 회사 자본의 중요한 확장을 나타내는 주목할 만한 변화가 있었습니다. 이 보고서는 2023년 12월부터 2024년 11월까지의 월별 데이터를 포함하여, 프랑스 Autorité des Marchés Financiers 규정에 따라 총 및 순 투표권을 추적하고 있습니다.
PHAXIAM Therapeutics a publié son rapport mensuel sur les droits de vote et la composition du capital social pour le 29 novembre 2024. Le nombre total d'actions de l'entreprise est resté stable à 10.013.719 depuis octobre 2024. Les droits de vote bruts ont légèrement augmenté pour atteindre 10.166.025, tandis que les droits de vote nets se sont élevés à 10.165.776.
Des changements notables ont eu lieu en juillet 2024 lorsque le nombre total d'actions est passé de 6.075.105 à 9.980.668, représentant une expansion significative du capital social de l'entreprise. Le rapport comprend des données mensuelles de décembre 2023 à novembre 2024, suivant à la fois les droits de vote bruts et nets conformément aux réglementations de l'Autorité des Marchés Financiers française.
PHAXIAM Therapeutics hat seinen monatlichen Bericht über Stimmrechte und die Zusammensetzung des Aktienkapitals für den 29. November 2024 veröffentlicht. Die Gesamtzahl der Aktien des Unternehmens blieb seit Oktober 2024 stabil bei 10.013.719. Die Bruttostimmrechte stiegen leicht auf 10.166.025, während die Nettostimmrechte bei 10.165.776 lagen.
Bemerkenswerte Änderungen traten im Juli 2024 auf, als die Gesamtanzahl der Aktien von 6.075.105 auf 9.980.668 anstieg, was eine signifikante Erweiterung des Aktienkapitals des Unternehmens darstellt. Der Bericht umfasst monatliche Daten von Dezember 2023 bis November 2024 und verfolgt sowohl die Brutto- als auch die Nettostimmrechte gemäß den Vorschriften der französischen Autorité des Marchés Financiers.
- Significant share capital expansion from 6.07M to ~10.01M shares in July 2024
- Stable share count maintained since October 2024
- Slight increase in voting rights indicating potential institutional interest
- None.
Article 223-16 of general regulation of French Autorité des Marchés Financiers
Listing market: Euronext Paris (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM)
Website : www.phaxiam.com
| Date | Total of shares composing the share capital | Total of brut (1) voting rights | Total of net (2) voting rights |
| December 31, 2023 | 6 075 105 | 6 226 982 | 6 226 733 |
| January 31, 2024 | 6 075 105 | 6 227 002 | 6 226 753 |
| February 29, 2024 | 6 075 105 | 6 226 951 | 6 226 702 |
| March 29, 2024 | 6 075 105 | 6 226 938 | 6 226 689 |
| April 30, 2024 | 6 075 105 | 6 226 932 | 6 226 683 |
| May 31, 2024 | 6 075 105 | 6 226 989 | 6 226 740 |
| July 1, 2024 | 9 980 668 | 10 132 597 | 10 132 348 |
| October 8, 2024 | 10 013 719 | 10 165 848 | 10 165 599 |
| October 31, 2024 | 10 013 719 | 10 165 846 | 10 165 597 |
| November 29, 2024 | 10 013 719 | 10 166 025 | 10 165 776 |
(1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2) Without treasury shares.
Attachment
FAQ
What is PHXM's current total number of shares as of November 29, 2024?
How many voting rights does PHXM have as of November 2024?
When did PHXM experience its most significant share capital increase in 2024?
